Health Care & Life Sciences » Pharmaceuticals | Flexion Therapeutics Inc.

Flexion Therapeutics Inc.

Flexion Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$4.48
Market Cap
$422.48 M
Shares Outstanding
37.99 M
Public Float
31.47 M

Profile

Address
10 Mall Road
Burlington Massachusetts 01803
United States
Employees -
Website http://www.flexiontherapeutics.com
Updated 07/08/2019
Flexion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. The firm specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand.

Financials

View All

Michael D. Clayman
President, Chief Executive Officer & Director
Patrick J. Mahaffy
Chairman